Skip to main content

Market Overview

Oppenheimer Reiterates Outperform Rating, $82 PT on Crown Castle International Corp.


In a report published Friday, Oppenheimer reiterated its Outperform rating and $82.00 price target on Crown Castle International Corp. (NYSE: CCI).

Oppenheimer noted, “CCI reported strong operating results, surpassing expectations although reported EPS of ($0.07) was impacted by a $117M debt retirement charge in 4Q12. As expected, management offered conservative FY13 guidance. However, the past three years CCI has outperformed initial FY guidance by 5-8%, partially through acquisitions and higher leverage. For the quarter, operating metrics were well above estimates and guidance, but higher D&A and interest expense caused EPS to miss our $0.21 estimate by 6 cents. Given the company's strong revenue pipeline and margin upside, we are increasing our FY13 estimates beyond the high end of guidance, but lowering EPS because of near-term margin dilution. Including T-Mobile, our current PT implies a 19.8x multiple.”

Crown Castle International Corp. closed on Thursday at $74.32.

Latest Ratings for CCI

May 2021Raymond JamesDowngradesOutperformMarket Perform
Apr 2021JP MorganMaintainsOverweight
Apr 2021RBC CapitalMaintainsOutperform

View More Analyst Ratings for CCI
View the Latest Analyst Ratings


Related Articles (CCI)

View Comments and Join the Discussion!

Posted-In: OppenheimerAnalyst Color Reiteration Analyst Ratings

Latest Ratings

PHXSeaport GlobalInitiates Coverage On
AFCGLake StreetInitiates Coverage On29.0
OSSNoble Capital MarketsUpgrades7.0
NCNOGabelli & Co.Upgrades
HAECJS SecuritiesUpgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at